VR

Vasant Raghunathappa Bhingole

Active Director Director DIN 08752627
DIN 08752627 First appointment Jan 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Vasant Raghunathappa Bhingole

Data last updated:

Vasant Raghunathappa Bhingole is a Director at Biocrest Life Sciences Private Limited (since 2022). The company operates in Chemicals.

DIN 08752627
Primary Designation Director
Industry Chemicals
First Appointment 13 Jan 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Jan 20222022Active

Board colleagues of Vasant Raghunathappa Bhingole

NameDINCompanyDesignation
Nishikant Joshi09466639Biocrest Life Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Biocrest Life Sciences Private Limited
Premium access

Shareholding and investment profile for Vasant Raghunathappa Bhingole

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vasant Raghunathappa Bhingole

Vasant Raghunathappa Bhingole currently holds 1 directorship: Biocrest Life Sciences Private Limited (Director, since 13 Jan 2022).

Vasant Raghunathappa Bhingole was first appointed on 13 Jan 2022 as Director at Biocrest Life Sciences Private Limited.

The current boards of Vasant Raghunathappa Bhingole's companies include Nishikant Joshi (Biocrest Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available